Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2017, Article ID 3916519, 9 pages
https://doi.org/10.1155/2017/3916519
Research Article

Immunomodulation of RA Patients’ PBMC with a Multiepitope Peptide Derived from Citrullinated Autoantigens

1Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, 5262100 Ramat-Gan, Israel
2Sackler Faculty of Medicine, Tel-Aviv University, 6997801 Tel-Aviv, Israel
3Department of Internal Medicine B, Sheba Medical Center, 5262100 Tel Hashomer, Israel
4Unité Différenciation Epithéliale et Autoimmunité Rhumatoïde, Université de Toulouse-INSERM, Toulouse, France
5Laboratoire de Biologie Cellulaire et Cytologie, CHU de Toulouse, Toulouse, France
6Incumbent of the Laura Schwarz-Kipp Chair for Research of Autoimmune Diseases, Tel Aviv University, 6997801 Tel Aviv, Israel

Correspondence should be addressed to Smadar Gertel; li.vog.htlaeh.abehs@letreg.radams

Received 23 January 2017; Revised 19 April 2017; Accepted 11 May 2017; Published 21 June 2017

Academic Editor: Tânia Silvia Fröde

Copyright © 2017 Smadar Gertel et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. B. Imboden, “The immunopathogenesis of rheumatoid arthritis,” Annual Review of Pathology, vol. 4, pp. 417–434, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. M. M. Nielen, D. van Schaardenburg, H. W. Reesink et al., “Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors,” Arthritis and Rheumatism, vol. 50, no. 2, pp. 380–386, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. P. F. Whiting, N. Smidt, J. A. Sterne et al., “Systematic review: accuracy of anti-citrullinated peptide antibodies for diagnosing rheumatoid arthritis,” Annals of Internal Medicine, vol. 152, no. 7, pp. 456–464, 2010, W155-466. View at Google Scholar
  4. A. Willemze, S. Bohringer, R. Knevel et al., “The ACPA recognition profile and subgrouping of ACPA-positive RA patients,” Annals of the Rheumatic Diseases, vol. 71, no. 2, pp. 268–274, 2012. View at Google Scholar
  5. C. Masson-Bessiere, M. Sebbag, E. Girbal-Neuhauser et al., “The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha- and beta-chains of fibrin,” Journal of Immunology, vol. 166, no. 6, pp. 4177–4184, 2001. View at Publisher · View at Google Scholar
  6. M. Simon, E. Girbal, M. Sebbag et al., “The cytokeratin filament-aggregating protein filaggrin is the target of the so-called “antikeratin antibodies,” autoantibodies specific for rheumatoid arthritis,” The Journal of Clinical Investigation, vol. 92, no. 3, pp. 1387–1393, 1993. View at Publisher · View at Google Scholar
  7. E. R. Vossenaar, N. Despres, E. Lapointe et al., “Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin,” Arthritis Research & Therapy, vol. 6, no. 2, pp. R142–R150, 2004. View at Publisher · View at Google Scholar
  8. R. Engelmann, A. Biemelt, A. Cordshagen, A. Johl, D. Kuthning, and B. Muller-Hilke, “The prerequisites for central tolerance induction against citrullinated proteins in the mouse,” PloS One, vol. 11, no. 6, article e0158773, 2016. View at Publisher · View at Google Scholar · View at Scopus
  9. I. Auger, M. Sebbag, C. Vincent et al., “Influence of HLA-DR genes on the production of rheumatoid arthritis-specific autoantibodies to citrullinated fibrinogen,” Arthritis and Rheumatism, vol. 52, no. 11, pp. 3424–3432, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. M. A. Gonzalez-Gay, C. Garcia-Porrua, and A. H. Hajeer, “Influence of human leukocyte antigen-DRB1 on the susceptibility and severity of rheumatoid arthritis,” Seminars in Arthritis and Rheumatism, vol. 31, no. 6, pp. 355–360, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. P. K. Gregersen, J. Silver, and R. J. Winchester, “The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis,” Arthritis and Rheumatism, vol. 30, no. 11, pp. 1205–1213, 1987. View at Publisher · View at Google Scholar · View at Scopus
  12. J. A. Hill, S. Southwood, A. Sette, A. M. Jevnikar, D. A. Bell, and E. Cairns, “Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule,” Journal of Immunology, vol. 171, no. 2, pp. 538–541, 2003. View at Publisher · View at Google Scholar
  13. S. C. Law, S. Street, C. H. Yu et al., “T-cell autoreactivity to citrullinated autoantigenic peptides in rheumatoid arthritis patients carrying HLA-DRB1 shared epitope alleles,” Arthritis Research & Therapy, vol. 14, no. 3, p. R118, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. A. H. van der Helm-van Mil, K. N. Verpoort, F. C. Breedveld, T. W. Huizinga, R. E. Toes, and R. R. de Vries, “The HLA-DRB1 shared epitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis,” Arthritis and Rheumatism, vol. 54, no. 4, pp. 1117–1121, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. C. C. Striebich, M. T. Falta, Y. Wang, J. Bill, and B. L. Kotzin, “Selective accumulation of related CD4+ T cell clones in the synovial fluid of patients with rheumatoid arthritis,” Journal of Immunology, vol. 161, no. 8, pp. 4428–4436, 1998. View at Google Scholar
  16. S. Turunen, M. K. Koivula, J. Melkko, E. Alasaarela, P. Lehenkari, and J. Risteli, “Different amounts of protein-bound citrulline and homocitrulline in foot joint tissues of a patient with anti-citrullinated protein antibody positive erosive rheumatoid arthritis,” Journal of Translational Medicine, vol. 11, p. 224, 2013. View at Google Scholar
  17. S. Gertel, G. Serre, Y. Shoenfeld, and H. Amital, “Immune tolerance induction with multiepitope peptide derived from citrullinated autoantigens attenuates arthritis manifestations in adjuvant arthritis rats,” Journal of Immunology, vol. 194, no. 12, pp. 5674–5680, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Gertel, Y. Shoenfeld, and H. Amital, “Tolerogenic citrullinated peptide for arthritis,” Oncotarget, vol. 6, no. 23, pp. 19344-19345, 2015. View at Publisher · View at Google Scholar
  19. C. Iobagiu, A. Magyar, L. Nogueira et al., “The antigen specificity of the rheumatoid arthritis-associated ACPA directed to citrullinated fibrin is very closely restricted,” Journal of Autoimmunity, vol. 37, no. 4, pp. 263–272, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Aggarwal, R. Srivastava, and S. Agrawal, “T cell responses to citrullinated self-peptides in patients with rheumatoid arthritis,” Rheumatology International, vol. 33, no. 9, pp. 2359–2363, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. N. Tandon, M. A. Freeman, and A. P. Weetman, “T cell responses to synthetic TSH receptor peptides in Graves' disease,” Clinical and Experimental Immunology, vol. 89, no. 3, pp. 468–473, 1992. View at Google Scholar
  22. M. Sebbag, S. Chapuy-Regaud, I. Auger et al., “Clinical and pathophysiological significance of the autoimmune response to citrullinated proteins in rheumatoid arthritis,” Joint, Bone, Spine, vol. 71, no. 6, pp. 493–502, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. K. Shin, S. Hong, E. H. Choi et al., “Role of citrullinated fibrinogen peptides in the activation of CD4 T cells from patients with rheumatoid arthritis,” Immune Network, vol. 13, no. 4, pp. 116–122, 2013. View at Publisher · View at Google Scholar
  24. H. Benham, H. J. Nel, S. C. Law et al., “Citrullinated peptide dendritic cell immunotherapy in HLA risk genotype-positive rheumatoid arthritis patients,” Science Translational Medicine, vol. 7, no. 290, p. 290ra287, 2015. View at Google Scholar
  25. A. L. Feitsma, E. I. van der Voort, K. L. Franken et al., “Identification of citrullinated vimentin peptides as T cell epitopes in HLA-DR4-positive patients with rheumatoid arthritis,” Arthritis and Rheumatism, vol. 62, no. 1, pp. 117–125, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. A. von Delwig, J. Locke, J. H. Robinson, and W. F. Ng, “Response of Th17 cells to a citrullinated arthritogenic aggrecan peptide in patients with rheumatoid arthritis,” Arthritis and Rheumatism, vol. 62, no. 1, pp. 143–149, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. D. M. Turley and S. D. Miller, “Prospects for antigen-specific tolerance based therapies for the treatment of multiple sclerosis,” Results and Problems in Cell Differentiation, vol. 51, pp. 217–235, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. E. A. James, M. Rieck, J. Pieper et al., “Citrulline-specific Th1 cells are increased in rheumatoid arthritis and their frequency is influenced by disease duration and therapy,” Arthritis & Rhematology, vol. 66, no. 7, pp. 1712–1722, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Miyara, Y. Yoshioka, A. Kitoh et al., “Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor,” Immunity, vol. 30, no. 6, pp. 899–911, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. C. Dominguez Mdel, N. Lorenzo, A. Barbera et al., “An altered peptide ligand corresponding to a novel epitope from heat-shock protein 60 induces regulatory T cells and suppresses pathogenic response in an animal model of adjuvant-induced arthritis,” Autoimmunity, vol. 44, no. 6, pp. 471–482, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Barbera, N. Lorenzo, G. Garrido et al., “APL-1, an altered peptide ligand derived from human heat-shock protein 60, selectively induces apoptosis in activated CD4+ CD25+ T cells from peripheral blood of rheumatoid arthritis patients,” International Immunopharmacology, vol. 17, no. 4, pp. 1075–1083, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Barbera, N. Lorenzo, P. van Kooten et al., “APL1, an altered peptide ligand derived from human heat-shock protein 60, increases the frequency of Tregs and its suppressive capacity against antigen responding effector CD4 + T cells from rheumatoid arthritis patients,” Cell Stress & Chaperones, vol. 21, no. 4, pp. 735–744, 2016. View at Publisher · View at Google Scholar · View at Scopus
  33. H. Chabre, Z. Amoura, J. C. Piette, P. Godeau, J. F. Bach, and S. Koutouzov, “Presence of nucleosome-restricted antibodies in patients with systemic lupus erythematosus,” Arthritis and Rheumatism, vol. 38, no. 10, pp. 1485–1491, 1995. View at Publisher · View at Google Scholar · View at Scopus
  34. L. Lu, A. Kaliyaperumal, D. T. Boumpas, and S. K. Datta, “Major peptide autoepitopes for nucleosome-specific T cells of human lupus,” The Journal of Clinical Investigation, vol. 104, no. 3, pp. 345–355, 1999. View at Publisher · View at Google Scholar
  35. L. Zhang, A. M. Bertucci, R. Ramsey-Goldman, E. R. Harsha-Strong, R. K. Burt, and S. K. Datta, “Major pathogenic steps in human lupus can be effectively suppressed by nucleosomal histone peptide epitope-induced regulatory immunity,” Clinical Immunology, vol. 149, no. 3, pp. 365–378, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. H. K. Kang, M. A. Michaels, B. R. Berner, and S. K. Datta, “Very low-dose tolerance with nucleosomal peptides controls lupus and induces potent regulatory T cell subsets,” Journal of Immunology, vol. 174, no. 6, pp. 3247–3255, 2005. View at Publisher · View at Google Scholar
  37. S. Nadkarni, C. Mauri, and M. R. Ehrenstein, “Anti-TNF-alpha therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-beta,” The Journal of Experimental Medicine, vol. 204, no. 1, pp. 33–39, 2007. View at Publisher · View at Google Scholar · View at Scopus